Amount Raised
$80M
Round Type
Series C
Date Raised
Jan 10, 2025
Open roles — actively hiring
Software EngineerProduct ManagerSales LeadMarketing+ 3 more
Get the founder's verified email + all open roles
Find my next client →About A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. — CREATING THE FUTURE OF PRECISION CELL THERAPIES operates in the biotechnology research sector and was founded in 2018. The company recently raised $80M in a Series C round (Jan 10, 2025), positioning the team to scale go-to-market, hire across functions, and evaluate new vendors over the coming quarter.
Why this raise matters
A2 Biotherapeutics, Inc. just closed $80M in Series C funding — which means they're actively scaling their team, upgrading their tech stack, and looking for vendors who can help them move fast. Companies at this stage typically make purchasing decisions within 60-90 days of closing a round. If you sell to biotechnology research companies, this is your window to reach out before competitors do.
Frequently asked questions
- How much did A2 Biotherapeutics, Inc. raise?
- A2 Biotherapeutics, Inc. raised $80M in a Series C round on Jan 10, 2025.
- Who founded A2 Biotherapeutics, Inc.?
- Founder information for A2 Biotherapeutics, Inc. is available on JustRaised.
- Where is A2 Biotherapeutics, Inc. based?
- Location details for A2 Biotherapeutics, Inc. are available in the JustRaised database.
- How do I contact the founders of A2 Biotherapeutics, Inc.?
- Verified founder emails and LinkedIn profiles for A2 Biotherapeutics, Inc. are available on a JustRaised paid plan.